tiprankstipranks
Trending News
More News >
Silo Pharma (SILO)
NASDAQ:SILO
US Market

Silo Pharma (SILO) Financial Statements

Compare
218 Followers

Silo Pharma Financial Overview

Silo Pharma's market cap is currently $4.60M. The company's EPS TTM is $-1.137; its P/E ratio is -0.35; Silo Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 72.10K$ 72.10K$ 72.10K$ 71.26K$ 0.00
Gross Profit$ 66.26K$ 66.26K$ 66.26K$ 66.26K$ 0.00
Operating Income$ -4.71M$ -3.86M$ -3.63M$ -2.74M$ -2.20M
EBITDA$ -4.38M$ -3.63M$ -3.91M$ 4.19M$ -2.40M
Net Income$ -4.39M$ -3.70M$ -3.91M$ 3.90M$ -3.04M
Balance Sheet
Cash & Short-Term Investments$ 7.08M$ 7.67M$ 11.37M$ 10.26M$ 1.13M
Total Assets$ 7.41M$ 7.75M$ 11.64M$ 10.49M$ 1.43M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 18.90K
Net Debt$ -3.91M$ -3.52M$ -11.37M$ -9.84M$ -1.11M
Total Liabilities$ 2.38M$ 1.57M$ 1.30M$ 1.43M$ 145.97K
Stockholders' Equity$ 5.03M$ 6.18M$ 10.34M$ 9.06M$ 1.28M
Cash Flow
Free Cash Flow$ -3.83M$ -3.22M$ -3.50M$ -2.28M$ -1.16M
Operating Cash Flow$ -3.83M$ -3.22M$ -3.50M$ -2.28M$ -1.16M
Investing Cash Flow$ 973.78K$ -4.15M$ 86.71K$ 7.19M$ 39.00K
Financing Cash Flow$ 3.24M$ -471.12K$ 4.94M$ 3.79M$ 2.13M
Currency in USD

Silo Pharma Earnings and Revenue History

Silo Pharma Debt to Assets

Silo Pharma Cash Flow

Silo Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.